NICE recommends new combination breast cancer drug
By Catherine Eckford (European Pharmaceutical Review)
New analysis sets stage for improved UK clinical trials
By Catherine Eckford (European Pharmaceutical Review)
Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers
By Courtney Soulsby (BSI)
CPI launches first-of-a-kind digitalisation framework
By Catherine Eckford (European Pharmaceutical Review)
Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing
By Andy Kavanagh (MSD Ireland), John Corcoran (MSD Ireland), Oliver…
The case for immigration concessions: maintaining the UK’s competitiveness in…
By Ana Sofia Walsh (Fragomen LLP), Rajiv Naik (Fragomen LLP)